CORD-19:48b81081bbcbdbea648394d8bf2adf370b36e44c / 50609-50708
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T35881","span":{"begin":0,"end":99},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The sample included postmenopausal breast cancer survivors taking adjuvant hormonal therapy (N=35)."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T31","span":{"begin":0,"end":99},"obj":"Sentence"}],"text":"The sample included postmenopausal breast cancer survivors taking adjuvant hormonal therapy (N=35)."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T10524","span":{"begin":35,"end":48},"obj":"Phenotype"}],"attributes":[{"id":"A40423","pred":"hp_id","subj":"T10524","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"The sample included postmenopausal breast cancer survivors taking adjuvant hormonal therapy (N=35)."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T25","span":{"begin":35,"end":41},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0000310"}],"text":"The sample included postmenopausal breast cancer survivors taking adjuvant hormonal therapy (N=35)."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T52260","span":{"begin":35,"end":48},"obj":"Disease"},{"id":"T69163","span":{"begin":42,"end":48},"obj":"Disease"},{"id":"T44006","span":{"begin":35,"end":48},"obj":"Disease"},{"id":"T88822","span":{"begin":42,"end":48},"obj":"Disease"}],"attributes":[{"id":"A38745","pred":"mondo_id","subj":"T52260","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A80479","pred":"mondo_id","subj":"T69163","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A69963","pred":"mondo_id","subj":"T44006","obj":"http://purl.obolibrary.org/obo/MONDO_0007254"},{"id":"A80765","pred":"mondo_id","subj":"T88822","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"The sample included postmenopausal breast cancer survivors taking adjuvant hormonal therapy (N=35)."}